These novel data suggest a distinct mechanism of RyR2 channel inhibitory action by CaM-N53I and CaM-A102V in CPVT, potentially via differential CaMKIIδ activation. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.